Progress report on the treatment of Cushing's disease.
D015065:17-Hydroxycorticosteroids / Q000032:analysis; D000237:Adenoma, Basophil / Q000532:radiotherapy; D000238:Adenoma, Chromophobe / Q000532:radiotherapy; D000293:Adolescent; D000315:Adrenalectomy; D000328:Adult; D002561:Cerebrovascular Disorders / Q000150:complications; D003480:Cushing Syndrome / Q000628:therapy*; D048909:Diabetes Complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007016:Hypophysectomy; D008297:Male; D008875:Middle Aged; D009502:Neutrons; D010910:Pituitary Irradiation; D010911:Pituitary Neoplasms / Q000517:prevention & control / Q000532:radiotherapy*; D010912:Pituitary-Adrenal Function Tests; D011085:Polycystic Ovary Syndrome / Q000150:complications; D011183:Postoperative Complications / Q000517:prevention & control / Q000532:radiotherapy*; D011247:Pregnancy; D012075:Remission, Spontaneous
D015065:17-Hydroxycorticosteroids; D006854:Hydrocortisone